Skip to main content
Contact Us
Subscribe
E-Edition
52°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Entertainment
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals Reports Positive Momentum in Second Quarter 2023
June 01, 2023
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
CPRX
Catalyst Pharmaceuticals Appoints Tamar Thompson to its Board of Directors
May 30, 2023
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
CPRX
Catalyst Pharmaceuticals Reports Record First Quarter 2023 Results, Achieving 98% Total Revenue Growth Year-over-Year
May 10, 2023
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
CPRX
Catalyst Pharmaceuticals Advances sNDA Submission Plans To Increase Indicated Maximum Dose For FIRDAPSE® From 80 mg Per Day To 100 mg Per Day
May 09, 2023
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
CPRX
Catalyst Pharmaceuticals Announces Release of Inaugural ESG Report
May 01, 2023
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
CPRX
Catalyst Pharmaceuticals to Report First Quarter 2023 Financial Results on May 10, 2023
April 24, 2023
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
CPRX
Catalyst Pharmaceuticals Announces Third-Party Abstracts on FYCOMPA® (Perampanel) to be Presented at the Upcoming American Academy of Neurology 2023 Annual Meeting
April 20, 2023
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
CPRX
Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 15, 2023
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
CPRX
Catalyst Pharmaceuticals Announces a Recent Third-Party Publication in Peer-Reviewed Journal Epilepsia Showing Perampanel (FYCOMPA®) Demonstrated High Efficacy in Patients with Rare Genetic Epilepsies
March 08, 2023
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
CPRX
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2022 Financial Results on March 15, 2023
March 01, 2023
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
CPRX
Catalyst Pharmaceuticals to Ring the Nasdaq Closing Bell in Honor of International Rare Disease Day
February 22, 2023
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
CPRX
Catalyst Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2022 Total Revenues and Provides Full Year 2023 Revenue Guidance
February 07, 2023
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
CPRX
Catalyst Pharmaceuticals Completes the Acquisition of U.S. Rights to FYCOMPA® (Perampanel) CIII
January 25, 2023
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
CPRX
Catalyst Pharmaceuticals Comments on FDA's Announcement of its Position on Orphan Drug Exclusivity In Light of the 11th Circuit Decision in Catalyst Pharmaceuticals, Inc. v. Becerra
January 23, 2023
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
CPRX
Catalyst Pharmaceuticals Notified of Abbreviated New Drug Application Filing for FIRDAPSE®
January 23, 2023
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
CPRX
Catalyst Pharmaceuticals to Acquire U.S. Commercial Rights to FYCOMPA® (Perampanel) CIII From Eisai Co., Ltd
December 19, 2022
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
CPRX
Catalyst Pharmaceuticals Reports Record Third Quarter 2022 Financial Results and Provides a Corporate Update
November 09, 2022
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
CPRX
Catalyst Pharmaceuticals Named BioFlorida 2022 Company of the Year
November 07, 2022
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
CPRX
Catalyst Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 9, 2022
October 25, 2022
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
CPRX
Catalyst Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for FIRDAPSE® Expanding Patient Population to Include Pediatric Patients
September 29, 2022
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
CPRX
Catalyst Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 9, 2022
July 26, 2022
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
CPRX
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.